Dr. Weili Wang

Case Western Reserve University, USA

Email: wxw336@case.edu

Qualifications

2014 Ph.D., Norman Bethune College of Medicine, Jilin University, China

2005 M.Sc., Norman Bethune College of Medicine, Jilin University, China

Publications (Selected)

1. Yu H, Lam K-O, Green MD, Wu H, Yang L, Wang W, Jin J-Y, Hu C, Wang Y, Jolly S, Kong F-M: Significance of Radiation Esophagitis: Conditional Survival Assessment in Patients with Non-Small Cell Lung Cancer. Journal of the National Cancer Center, 2021
2. Zhang H, Wang W, Pi W, Bi N, DesRosierse C, Kong V, Cheng M, Yang L, Jolly S, Jin J, Kong F: Genetic variations in the transforming growth factor-β1 pathway may improve predictive power for overall survival in non-small cell lung cancer. Frontiers in Oncology, 2021 (In Press)
3. Jin J-Y, Gu A, Wang W, Oleinick NL, Machtay M, Kong F-M: Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect? Radiotherapy and Oncology 149:55-62, 2020
4. Wang W, Matuszak MM, Hu C, Huang KC, Chen E, Arenberg D, Curtis JL, Jolly S, Jin J-Y, Machtay M, Ten Haken RK, Kong F-M: Central Airway Toxicity After High Dose Radiation: A Combined Analysis of Prospective Clinical Trials for Non-Small Cell Lung Cancer. International Journal of Radiation Oncology Biology Physics 108:587-596, 2020.
5. Wang W, Huang L, Jin J-Y, Pi W, Ellsworth SG, Jolly S, Mellor AL, Machtay M, Kong F-M: A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease. Clinical Cancer Research 26:282-289, 2020.
6. Wang W, Huang L, Jin J-Y, Jolly S, Zang Y, Wu H, Yan L, Pi W, Li L, Mellor AL, Kong F-M: IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients. Cancer Research 78:809-816, 2018.
7. Wang W, Zhong W, Chen C, Meng Q, Wei J: Circulating Antibodies to Linear Peptide Antigens Derived from ANXA1 and FOXP3 in Lung Cancer. Anticancer Research 37:3151-3155, 2017 (Corresponding author).
8. Wang W, Zhong W, Liu D, Zhang G, Zhou C, Guo G, Liu X: Correlations between patterns of failure of small cell lung cancer and radiotherapy fraction. Journal of Modern Oncology 25:216-219, 2017 (Corresponding author).
9. Wang W, Guan S, Sun S, Jin Y, Lee K-H, Chen Y, Wei J: Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer. Tumor Biology 35:4901-4905, 2014.
10. Wang W, Xu Y, Schipper M, Matuszak MM, Ritter T, Cao Y, Ten Haken RK: Effect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning. International Journal of Radiation Oncology* Biology* Physics 86:956-963, 2013.
11. Wang W, Ye L, Li X, Guan S, Sun S, Wang M, Guan X, Lee K-H, Wei J, Liu B: Circulating IgG antibody against FOXP3 may be a potential biomarker for lung cancer. Advances in Lung Cancer 2:79, 2013 (Corresponding author).
12. Wang W, Zhou C, Zhang G, Sun C, Liu X: Correlation between Lactate Dehydrogenase and Neuron Enolase Levels and Prognosis of Small Cell Lung Cancer before Treatment. Chinese Journal of Gerontology: 2272-2274, 2013 (Corresponding author).
13. Wang W, Zhang X, Liu D, Guo G, Zhang X, Liu J: The role of cardiac dosimetry parameters in predicting radiation heart disease. Chinese Journal of Gerontology 33:2751-2752, 2013 (Corresponding author).
14. Wang W, Pan H, Zhong W, Guo G, Zhou C, Zhang G: Association of ERCC1 gene polymorphism with the prognosis of non-small cell lung cancer. Chinese Journal of Laboratory Diagnosis 17:854-857, 2013 (Corresponding author).
15. Wang W, Liu D, Guo G, Zhong W, Sun C, Liu X: Study on the relationship between thoracic radiotherapy segmentation and the prognosis of small cell lung cancer. Chinese Journal of Laboratory Diagnosis 17:680-682, 2013 (Corresponding author).
16. Wang W, Liu L, Liu X, Wu Z, Gong S, Shao G: Association of MDM2 Gene Polymorphisms with Radiosensitivity and Susceptibility to NSCLC. Chinese Journal of Radiation Oncology: 60-61, 2006.